Get started
Author

Willy Teng

Observed names: W Teng, W. Teng
Observed institution: Takeda Oncology (United States)
OpenAlex ID: A5079725909
Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function.
1992 · R.M. Scarborough, M.A. Naughton, et al. · Journal of Biological Chemistry · 290
Ligand Cross-reactivity within the Protease-activated Receptor Family
1996 · Brian D. Blackhart, Kjell Emilsson, et al. · Journal of Biological Chemistry · 208
Extracellular Mutations of Protease-Activated Receptor-1 Result in Differential Activation by Thrombin and Thrombin Receptor Agonist Peptide
2000 · Brian D. Blackhart, Lily Ruslim-Litrus, et al. · Molecular Pharmacology · 68
Substituted acrylamides as factor Xa inhibitors: improving bioavailability by P1 modification
2002 · Yonghong Song, Lane Clizbe, et al. · Bioorganic & Medicinal Chemistry Letters · 36
Design and synthesis of factor Xa inhibitors and their prodrugs
2003 · Yonghong Song, Lane Clizbe, et al. · Bioorganic & Medicinal Chemistry Letters · 26
Design, synthesis, and SAR of substituted acrylamides as factor Xa inhibitors
2002 · Yonghong Song, Lane Clizbe, et al. · Bioorganic & Medicinal Chemistry Letters · 13
Thrombin receptor antagonists derived from “tethered ligand”agonist peptides
1994 · R. M. Scarborough, W. Teng, et al. · Springer eBooks · 4
Design, synthesis, and SAR of substituted acrylamide as inhibitors of human Factor Xa
2001 · Yadong Song, Lane A. Clizbe, et al. · Abstracts of papers - American Chemical Society
Design, synthesis and structure-activity relationships of benzazepinone-based transition state factor Xa inhibitors
1999 · Bing Zhu, Hua Yang, et al. · Abstracts of papers - American Chemical Society
Works count: 9
Citation count: 645
H-index: 6
I10-index: 6
Year
Topic
Type